🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.050
0.00 (0.00%)
At close: Nov 18, 2026, 4:00 PM EST
1.060
+0.010 (0.95%)
Pre-market: Nov 19, 2026, 8:52 AM EST

Vivani Medical Statistics

Total Valuation

Vivani Medical has a market cap or net worth of $94.71 million. The enterprise value is $97.53 million.

Market Cap94.71M
Enterprise Value 97.53M

Important Dates

The last earnings date was Wednesday, November 11, 2026, after market close.

Earnings Date Nov 11, 2026
Ex-Dividend Date n/a

Share Statistics

Vivani Medical has 90.20 million shares outstanding. The number of shares has increased by 40.02% in one year.

Current Share Class 90.20M
Shares Outstanding 90.20M
Shares Change (YoY) +40.02%
Shares Change (QoQ) +3.48%
Owned by Insiders (%) 49.96%
Owned by Institutions (%) 6.42%
Float 38.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.17
P/TBV Ratio 7.17
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 1.32.

Current Ratio 2.40
Quick Ratio 2.26
Debt / Equity 1.32
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -372.18% and return on invested capital (ROIC) is -70.08%.

Return on Equity (ROE) -372.18%
Return on Assets (ROA) -58.33%
Return on Invested Capital (ROIC) -70.08%
Return on Capital Employed (ROCE) -98.04%
Weighted Average Cost of Capital (WACC) 19.03%
Revenue Per Employee n/a
Profits Per Employee -$643,643
Employee Count42
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.57% in the last 52 weeks. The beta is 3.32, so Vivani Medical's price volatility has been higher than the market average.

Beta (5Y) 3.32
52-Week Price Change -28.57%
50-Day Moving Average 1.16
200-Day Moving Average 1.23
Relative Strength Index (RSI) 42.95
Average Volume (20 Days) 285,272

Short Selling Information

The latest short interest is 369,789, so 0.41% of the outstanding shares have been sold short.

Short Interest 369,789
Short Previous Month 417,148
Short % of Shares Out 0.41%
Short % of Float 0.95%
Short Ratio (days to cover) 2.24

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -28.16M
Pretax Income -27.03M
Net Income -27.03M
EBITDA -27.66M
EBIT -28.16M
Earnings Per Share (EPS) -$0.33
Full Income Statement

Balance Sheet

The company has $14.59 million in cash and $17.41 million in debt, with a net cash position of -$2.82 million or -$0.03 per share.

Cash & Cash Equivalents 14.59M
Total Debt 17.41M
Net Cash -2.82M
Net Cash Per Share -$0.03
Equity (Book Value) 13.22M
Book Value Per Share 0.15
Working Capital 9.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.34 million and capital expenditures -$376,000, giving a free cash flow of -$25.72 million.

Operating Cash Flow -25.34M
Capital Expenditures -376,000
Depreciation & Amortization 502,000
Net Borrowing -356,000
Free Cash Flow -25.72M
FCF Per Share -$0.29
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Vivani Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -40.02%
Shareholder Yield -40.02%
Earnings Yield -31.29%
FCF Yield -27.15%

Analyst Forecast

The average price target for Vivani Medical is $3.83, which is 265.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.83
Price Target Difference 265.05%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2